59262-6 |
Leukocyte esterase |
PrThr |
CSF |
Pt |
Ord |
Test strip |
|
ACTIVE |
Leukocyte esterase [Presence] in Cerebral spinal fluid by Test strip |
|
MIN |
DefinitionDescription |
|
|
|
POS or NEG |
|
|
|
|
|
UA |
|
59262-6 |
|
Test strip |
|
|
Both |
|
|
|
0 |
Leukocyte esterase CSF Ql Strip |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Dip stick; Dipstick; Leuc; Leuk; Leukocytes; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; URINALYSIS; WBC; WBCs; White blood cell; White blood cells |
2.7 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59263-4 |
Human papilloma virus 16 DNA |
PrThr |
Cvx |
Pt |
Ord |
Probe.amp.sig |
|
ACTIVE |
Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification |
|
MIN |
DefinitionDescription |
|
|
|
Positive, Negative |
|
|
|
|
|
MICRO |
|
59263-4 |
|
Probe.amp.sig |
|
|
Both |
|
|
|
0 |
HPV16 DNA Cvx Ql Probe+sig amp |
|
|
|
N |
|
Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV16; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Property changed from ACnc to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59264-2 |
Human papilloma virus 18 DNA |
PrThr |
Cvx |
Pt |
Ord |
Probe.amp.sig |
|
ACTIVE |
Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification |
|
MIN |
DefinitionDescription |
|
|
|
Positive, Negative |
|
|
|
|
|
MICRO |
|
59264-2 |
|
Probe.amp.sig |
|
|
Both |
|
|
|
0 |
HPV18 DNA Cvx Ql Probe+sig amp |
|
|
|
N |
|
Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; Gyn; Gynecology; HC; HPA; HPV; HPV18; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Papilloma virus high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Property changed from ACnc to fit the current LOINC model.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59265-9 |
8-Hydroxydeoxyguanosine/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
8-Hydroxydeoxyguanosine/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mg creatinine |
Numeric ratio |
|
|
|
|
|
CHEM |
|
59265-9 |
|
|
|
|
Observation |
|
|
|
0 |
8OH-deoxyguanosine/Creat Ur |
|
|
|
N |
|
8-Hydroxy-deoxyguanosine; 8OH-deoxyguanosine; 8-OHdG; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mg{creat} |
|
|
|
0 |
59266-7 |
Maternal cell contamination |
Prid |
XXX |
Pt |
Nom |
|
|
ACTIVE |
Maternal cell contamination [Identifier] in Specimen Nominal |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
59266-7 |
|
|
|
|
Both |
|
|
|
0 |
Maternal Cell Contam Spec |
|
|
|
N |
|
Identity or presence; MCC; Misc; Miscellaneous; Molecular pathology; MOLPATH; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59267-5 |
Karyotype |
Prid |
Bld/Tiss |
Pt |
Nar |
FISH |
|
ACTIVE |
Karyotype [Identifier] in Blood or Tissue by FISH Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
59267-5 |
|
FISH |
|
|
Observation |
|
|
|
0 |
Karyotyp Bld/T FISH |
|
|
|
N |
|
Blood; Chromosome analysis; Fluorescent in situ hybridization; Genetics; Genotype; Heredity; Heritable; Identity or presence; Inherited; Karyogram; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59268-3 |
Neonatal care report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Neonatal care report |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
59268-3 |
|
|
|
|
Both |
|
|
|
0 |
Neonatal care report |
|
|
|
N |
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random |
2.73 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59269-1 |
Respiratory severity score |
Pres |
Respiratory system.airway+Inhl Gas |
Pt |
Qn |
|
|
ACTIVE |
Respiratory severity score |
|
MIN |
DefinitionDescription |
|
|
cm H2O |
|
|
RSS= Mean Airway Pressure(MAP) P x FiO2 |
|
|
|
PULM |
|
59269-1 |
|
|
|
|
|
|
|
|
0 |
Respiratory severity score |
|
|
|
N |
|
Breathing; Gases; IhG; Inhaled Gas; Inspired; Lung; Lungs; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS |
2.5 |
2.32 |
|
|
|
|
|
|
|
cm[H2O] |
|
|
|
0 |
5927-9 |
Potassium |
SCnc |
Dial fld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Potassium [Molecules/volume] in Dialysis fluid |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
5927-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated Potassium Dial fld-sCnc |
|
|
|
|
|
Chemistry; Diaf; Dialysate; Dialysis fluid; k; K+; Level; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.36 |
1.0b |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
59270-9 |
Surgical operative note panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Surgical operative note panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DOC |
|
59270-9 |
|
|
|
|
|
|
|
|
0 |
Surgical operative note pnl |
|
|
|
N |
|
Encounter; Evaluation and management; Evaluation and management note; notes; Pan; PANEL.DOC; Panl; Pnl; Point in time; Random; Surg; Surgical operative note pnl; Visit note |
2.32 |
2.32 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
59271-7 |
Hospital discharge summary panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Hospital discharge summary panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DOC |
|
59271-7 |
|
|
|
|
|
|
|
|
0 |
Hospital discharge summary pnl |
|
|
|
N |
|
Disch; Hosp; Hospital discharge summary pnl; Pan; PANEL.DOC; Panl; Pnl; Point in time; Random |
2.32 |
2.32 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
59272-5 |
Power setting |
Arb |
Ventilator |
Pt |
Ord |
|
|
ACTIVE |
Power setting Ventilator |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PULM |
|
59272-5 |
|
|
|
|
Observation |
|
|
|
0 |
Power setting Vent |
|
|
|
N |
|
Arbitrary; Lung; Ordinal; Point in time; PULMONARY; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen |
2.7 |
2.32 |
|
|
|
|
|
|
|
|
|
|
|
0 |
59273-3 |
Cortisol^post 6 mg dexamethasone PO overnight |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Serum or Plasma --post 6 mg dexamethasone PO overnight |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHAL |
|
59273-3 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis p 6 mg Dex SerPl-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; Mass concentration; p 6 mg Dex; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.34 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
59274-1 |
Oxygen content |
VFr |
BldA |
Pt |
Qn |
Calculated |
|
ACTIVE |
Oxygen content in Arterial blood by calculation |
|
MIN |
DefinitionDescription |
|
|
ml/dl |
|
|
Sa02 x 1.34 x Hb + .003 x PO2 |
|
|
|
CHEM |
|
59274-1 |
|
Calculated |
|
|
Observation |
|
|
|
0 |
O2 Ct VFr BldA Calc |
|
|
|
N |
|
ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Calc; Calculation; Chemistry; ctO2; Lung; O2; O2 Ct; O2CT; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2; Volfr; Volume fraction |
2.73 |
2.32 |
|
|
|
|
|
|
|
mL/dL |
|
|
|
0 |
59275-8 |
Oxygen capacity |
VFr |
BldA |
Pt |
Qn |
|
|
ACTIVE |
Oxygen capacity [Volume Fraction] in Arterial blood |
|
MIN |
DefinitionDescription |
|
|
ml/dl |
|
|
|
|
|
|
CHEM |
|
59275-8 |
|
|
|
|
Observation |
|
|
|
0 |
O2 Cap VFr BldA |
|
|
|
N |
|
ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; O2; O2 Cap; O2Cap; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Volfr; Volume fraction |
2.73 |
2.32 |
|
|
|
|
|
|
|
mL/dL |
|
|
|
0 |
59276-6 |
Calcium hydrogen phosphate dihydrate crystals |
PrThr |
Calculus |
Pt |
Ord |
XR diffraction |
|
ACTIVE |
Calcium hydrogen phosphate dihydrate crystals [Presence] in Stone by X-ray diffraction |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
59276-6 |
|
XR diffraction |
|
|
Observation |
|
|
|
0 |
Ca H2 Phos dihyd Cry Stone Ql XR diff |
|
|
|
N |
|
Brushite; Ca; Ca H2 Phos dihyd; Ca H2 Phos dihyd Cry; Cal; Calc; Calculi; Chemistry; CHPD; Crys; Cryst; Crystal; Gastro; Gastroenterology; GI; H2; Hyd; i Phos; Inorganic phosphate; Kidney; Nephrology; Ordinal; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Plain Films; PO4; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; Xray; X-ray |
2.56 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59277-4 |
Cystine crystals |
PrThr |
Calculus |
Pt |
Ord |
XR diffraction |
|
ACTIVE |
Cystine crystals [Presence] in Stone by X-ray diffraction |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
59277-4 |
|
XR diffraction |
|
|
Observation |
|
|
|
0 |
Cystine Cry Stone Ql XR diff |
|
|
|
N |
|
Calc; Calculi; Chemistry; Crys; Cryst; Crystal; Cys-Cys; Dicysteine; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; Xray; X-ray |
2.56 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59278-2 |
Calcium oxalate dihydrate crystals |
PrThr |
Calculus |
Pt |
Ord |
XR diffraction |
|
ACTIVE |
Calcium oxalate dihydrate crystals [Presence] in Stone by X-ray diffraction |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
59278-2 |
|
XR diffraction |
|
|
Observation |
|
|
|
0 |
COD Cry Stone Ql XR diff |
|
|
|
N |
|
Ca; CaC2O4; CaC2O4.2H2O; Cal; Calc; Calculi; CaOx; Chemistry; COD Cry; Crys; Cryst; Crystal; Ethanedioate; Ethanedioic acid; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Oxal; Oxalic acid; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; Weddellite; Xray; X-ray |
2.56 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59279-0 |
Urate crystals |
PrThr |
Calculus |
Pt |
Ord |
XR diffraction |
|
ACTIVE |
Urate crystals [Presence] in Stone by X-ray diffraction |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
59279-0 |
|
XR diffraction |
|
|
Observation |
|
|
|
0 |
Urate Cry Stone Ql XR diff |
|
|
|
N |
|
Calc; Calculi; Chemistry; Crys; Cryst; Crystal; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; UA; Urates; Uric acid; Xray; X-ray |
2.56 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
5928-1 |
Chloride |
SCnc |
Dial fld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Chloride [Molecules/volume] in Dialysis fluid |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
5928-1 |
|
|
|
|
|
|
|
|
0 |
Deprecated Chloride Dial fld-sCnc |
|
|
|
|
|
Chemistry; Cl; Cl-; Diaf; Dialysate; Dialysis fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.36 |
1.0b |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
59280-8 |
Urate dihydrate crystals |
PrThr |
Calculus |
Pt |
Ord |
XR diffraction |
|
ACTIVE |
Urate dihydrate crystals [Presence] in Stone by X-ray diffraction |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
59280-8 |
|
XR diffraction |
|
|
Observation |
|
|
|
0 |
Urate dihyd Cry Stone Ql XR diff |
|
|
|
N |
|
Calc; Calculi; Chemistry; Crys; Cryst; Crystal; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Plain Films; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; UA; Urate dihyd Cry; Urates; Uric acid; Xray; X-ray |
2.56 |
2.32 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59281-6 |
Multisection transthoracic |
Find |
Chest>Heart |
Pt |
Doc |
US |
|
ACTIVE |
US Heart Transthoracic |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CARD.US |
|
59281-6 |
|
US |
|
|
Both |
|
|
|
0 |
US Heart Transthoracic |
|
|
|
N |
|
CARD.US; Cardiac; Cardio; Cardiology; Document; Echography; Finding; Findings; Heart Disease; Hrt; Point in time; Random; Sonogram; Sonograph; Sonography; Thorax; ULS; Ultrasound |
2.64 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Changed Component Name from Transthoracic cardiac study report and changed system based on current LOINC model |
0 |
59282-4 |
Cardiac stress echo study |
Find |
Heart |
Pt |
Doc |
US |
|
ACTIVE |
Cardiac stress echo study |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CARD.US |
|
59282-4 |
|
US |
|
|
Both |
|
|
|
0 |
Stress cardiac echo study |
|
|
|
N |
|
CARD.US; Cardiac; Cardio; Cardiology; Document; Echography; Finding; Findings; Heart Disease; Hrt; Point in time; Random; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound |
2.72 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Release 2.72: COMPONENT: Update naming convention for studies; |
0 |
59283-2 |
Well child visit note |
Find |
{Setting} |
Pt |
Doc |
{Role} |
|
ACTIVE |
Well child visit note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
59283-2 |
|
{Role} |
|
|
Both |
|
|
|
0 |
Well child visit note |
|
|
|
N |
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note |
2.67 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Based on Clinical LOINC Committee decision during the September 2014 meeting, {Provider} was changed to {Author Type} to emphasize a greater breadth of potential document authors. At the September 2015 Clinical LOINC Committee meeting, the Committee decided to change {Author Type} to {Role} to align with the 'Role' axis name in the LOINC Document Ontology. |
0 |
59284-0 |
Consent |
Find |
{Setting} |
Pt |
Doc |
Patient |
|
ACTIVE |
Consent Document |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
59284-0 |
|
Patient |
|
|
Both |
|
|
|
0 |
Consent |
|
|
|
N |
|
DOC.ONT; Document; Finding; Findings; Form; Point in time; Random |
2.65 |
2.32 |
|
|
|
|
|
|
|
|
|
|
Removed "Patient" from Long Common Name and Shortname. |
0 |